作为潜在的抗癌剂的新型氧-乙烯 (乙烯) 烯-2-衍生物
Wenxin Xu1, Yali Du1,2, Beibin Pan1
1School of Pharmaceutical Sciences, Wenzhou Medical University, Zhejiang, China.
BMC chemistry
|November 29, 2023
概括
新型化合物通过诱导亡诱导瘤细胞死亡,显示出强大的抗癌作用. 化合物3h在体内表现出显著的抗增殖活性和抗瘤作用,没有明显的毒性.
科学领域:
- 药用化学 医学化学
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 烯化合物因其对健康细胞的保护作用和诱导瘤细胞亡的能力而闻名,使其成为癌症研究的有希望的候选人.
- 新型有机衍生物的合成和评估对于开发新的抗癌剂至关重要.
研究的目的:
- 合成和评估新型氧-乙烯基烯-2-醇衍生物对人类癌症细胞系的抗增殖活性.
- 确定具有强烈抗瘤活性的特定化合物并阐明它们的作用机制.
主要方法:
- 合成了23种新型的氧-乙烯 (乙烯) -2-衍生物.
- 在体外抗扩散测试对人类癌症细胞系进行测试.
- 流细胞计分析细胞周期阶段停止和亡诱导.
- 西方斑分析用于评估细胞循环和亡相关蛋白质的变化.
- 在裸体小鼠体内的异种移植瘤实验和毒性影响的评估.
主要成果:
- 大多数合成的化合物都表现出显著的抗增殖活性.
- 含有素替代物的3h,3g和3h-2化合物显示出最强的抗瘤活性.
- 化合物3h,3g和3h-2诱导了A549细胞中的G2/M阶段停止和亡.
- 化合物3h在异种移植模型中体内表现出抗瘤作用,没有明显的毒性,并减轻了西斯胺诱导的器官损伤.
结论:
- 新型有机化合物,特别是3h等基衍生物,表现出强大的抗癌特性.
- 化合物3h有效诱导亡并抑制体内瘤生长,这表明它有可能成为癌症治疗的主要化合物.
- 化合物3h在癌症治疗中表现有前途,具有良好的安全性和保护作用,防止化疗引起的器官损伤.
相关概念视频
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
303
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
303
Inhibition of Cdk Activity
4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K


